Qi Siyuan, Yang Qianqian, Hu Shihai, Wang Yitong, Yang Jiaqi, Li Jie, Wang Lina, Zhang Yan
School of Nursing (S.Q., Q.Y., S.H., Y.W., J.Y., J.L., L.W.), Xinxiang Medical University, Xinxiang City, Henan Province, China.
School of Nursing (S.Q., Q.Y., S.H., Y.W., J.Y., J.L., L.W.), Xinxiang Medical University, Xinxiang City, Henan Province, China.
J Pain Symptom Manage. 2025 Mar;69(3):e247-e256. doi: 10.1016/j.jpainsymman.2024.11.018. Epub 2024 Dec 18.
Hemodialysis (HD) patients often face a heavy symptom burden, low subjective well-being, and high perceived stress. Traditional nonpharmacological interventions have limited effectiveness in improving this situation. Virtual reality (VR) technology, as an emerging approach, has shown significant advantages in alleviating symptom burden and enhancing mental health.
To assess the feasibility of a single VR travel session for HD patients and to examine its impact on symptom burden, subjective well-being, and perceived stress.
This study adopted an embedded design, providing approximately 10 minutes of natural VR travel experience using VR head-mounted displays (HMD). The effectiveness of a single VR travel session for HD patients was evaluated. Quantitative data were collected through self-reported surveys using the Dialysis Frequency Severity and Symptom Burden Index (DFSSBI) to assess symptom burden, the General Well-Being Schedule (GWBS), and the Perceived Stress Scale (PSS) to evaluate well-being and stress. Postintervention, a modified single-item questionnaire assessed patient satisfaction with the VR travel experience. An open-ended question was included to capture patients' experiential feedback.
Twenty HD patients, with a mean age of 41.30 (9.82) years, completed the VR travel and subsequent assessments. The cohort comprised 35% female and 65% male participants. The VR travel significantly improved symptom burden (t = 3.64, P = 0.002), increased subjective well-being (t = -6.12, P < 0.001), and reduced perceived stress (t = 4.16, P = 0.001). The postintervention satisfaction score was 7.35 (1.35) out of 10, and participants provided positive feedback on their VR travel experience.
A single VR travel session can alleviate symptom burden, enhance subjective well-being, and reduce perceived stress in HD patients. Participants reported high satisfaction and positive emotional responses, suggesting that this experience could be integrated into care routines as a nonpharmacological intervention to improve symptom burden and mental health in HD patients.
[www.chictr.org.cn], identifier [ChiCTR2400082781].
血液透析(HD)患者常常面临沉重的症状负担、较低的主观幸福感和较高的感知压力。传统的非药物干预在改善这种情况方面效果有限。虚拟现实(VR)技术作为一种新兴方法,在减轻症状负担和促进心理健康方面显示出显著优势。
评估单次VR旅行体验对HD患者的可行性,并研究其对症状负担、主观幸福感和感知压力的影响。
本研究采用嵌入式设计,使用VR头戴式显示器(HMD)为患者提供约10分钟的自然VR旅行体验。评估单次VR旅行体验对HD患者的有效性。通过自我报告调查收集定量数据,使用透析频率严重程度和症状负担指数(DFSSBI)评估症状负担,使用总体幸福感量表(GWBS)和感知压力量表(PSS)评估幸福感和压力。干预后,通过一份修改后的单项问卷评估患者对VR旅行体验的满意度。还设置了一个开放式问题以获取患者的体验反馈。
20名HD患者完成了VR旅行及后续评估,平均年龄为41.30(9.82)岁。该队列中女性参与者占35%,男性参与者占65%。VR旅行显著减轻了症状负担(t = 3.64,P = 0.002),提高了主观幸福感(t = -6.12,P < 0.001),并降低了感知压力(t = 4.16,P = 0.001)。干预后的满意度评分为7.35(1.35)(满分10分),参与者对VR旅行体验给予了积极反馈。
单次VR旅行体验可减轻HD患者的症状负担,提高主观幸福感,并降低感知压力。参与者报告了较高的满意度和积极的情绪反应,表明这种体验可作为一种非药物干预措施纳入护理常规,以改善HD患者的症状负担和心理健康。